Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 4,035.00
-15.00 (-0.37%)
At close: Sep 22, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 44.55 billion as of September 22, 2026. Its market cap has decreased by -38.31% in one year.
Market Cap
44.55B
Enterprise Value
35.43B
Revenue
19.60B
Ranking
n/a
PE Ratio
14.79
Stock Price
4,035.00
ChartMarket Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 44.55B, a decrease of -51.94%. That is a compound annual growth rate of -33.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 44.55B | -39.45% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NBR Motion | 71.89B |
| ERCOHS Agricultural Corporation Co.,Ltd | 53.47B |
| ALT Co., Ltd. | 50.37B |
| Laseroptek | 46.24B |
| C-SITE | 38.86B |
| GITSN | 35.47B |
| Catis. | 29.98B |
| New Kids On | 28.30B |